Search Results - "Crafa, P."

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma by Bozzetti, C, Negri, F V, Lagrasta, C A, Crafa, P, Bassano, C, Tamagnini, I, Gardini, G, Nizzoli, R, Leonardi, F, Gasparro, D, Camisa, R, Capelli, S, Silini, E M, Ardizzoni, A

“…Background: Trastuzumab has recently shown efficacy in the treatment of HER2-positive advanced gastric adenocarcinoma. Although antibody-based therapies target…”
Get full text

PTEN status in advanced colorectal cancer treated with cetuximab by Negri, F V, Bozzetti, C, Lagrasta, C A, Crafa, P, Bonasoni, M P, Camisa, R, Pedrazzi, G, Ardizzoni, A

“…Background: Loss of phosphatase and tensin homologue deleted in chromosome 10 (PTEN) function in advanced colorectal cancer (CRC) may represent one of the…”
Get full text

Neuroendoscopic management of posterior third ventricle and pineal region tumors: technique, limitation, and possible complication avoidance by Chibbaro, S., Di Rocco, F., Makiese, O., Reiss, A., Poczos, P., Mirone, G., Servadei, F., George, B., Crafa, P., Polivka, M., Romano, A.

“…The endoscopic approach has gained an increased popularity in recent years for the biopsy and, in selected cases, the removal of tumors of the posterior third…”
Get full text

Biological predictive factors in rectal cancer treated with preoperative radiotherapy or radiochemotherapy by Negri, F V, Campanini, N, Camisa, R, Pucci, F, Bui, S, Ceccon, G, Martinelli, R, Fumagalli, M, Losardo, P L, Crafa, P, Bordi, C, Cascinu, S, Ardizzoni, A

“…We analysed the expression of microsatellite instability, p53, p21, vascular endothelial growth factor and thymidylate synthase (TS) in pretreatment biopsy…”
Get full text

P.02.18: Non Invasive Diagnosis of Upper Gi Diseases in a Primary Care Setting: A Study on 1,900 Patients by Di Mario, F, Cesario, S, Grillo, S, Landi, S, Baldassarre, G, Cannizzaro, R, Crafa, P, Roberti, F.M, Riccò, M, Bertelè, A, Corrente, V, Scarpignato, C, Rugge, M

Get full text

P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area by Crafa, P, Caruana, P, Mancini, C, Meiattini, G, Corrente, V, Gnocchi, A, Cavestro, G.M, Dell’Abate, P, Costi, R, Cannizzaro, R, Rugge, M, Di Mario, F

Get full text

P.02.9: Prevalence of Atrophic Gastritis in General Population: A Gastropanel®-Based Study, Compared with Olga Histological Classification by Roberti, F.M, Grillo, S, Cesario, S, Landi, S, Crafa, P, Cannizzaro, R, Grande, G, Corrente, V, Franceschi, M, Riccò, M, Scarpignato, C, Rugge, M, Di Mario, F

Get full text

P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination by Franceschi, M, Panozzo, P, Miraglia, C, Antico, A, Baldassarre, G, Scida, S, Uziel, E, Grillo, S, Landi, S, Cannizzaro, R, Crafa, P, Scarpignato, C, Rugge, M, Di Mario, F

Get full text

P.02.2: Improvement of Symptoms in Patients Affected by Chronic Athrophic Gastritis: A 2 Years Prospective Study by using L-Cysteine (Acetium™) by Grillo, S, Landi, S, Miraglia, C, Crafa, P, Scida, S, Franceschi, M, Cannizzaro, R, Goni, E, Dal Bò, N, Scarpignato, C, Rugge, M, Di Mario, F

Get full text

P.01.5: Serum Pepsinogen II as a Non-Invasive Marker for Diagnosis of Helicobacter Pylori Infection: A Prospective Study in a Cohort of Dyspeptic Patients by Grillo, S, Landi, S, Violi, A, Franceschi, M, Masciangelo, G, Baldassarre, G, Rugge, M, Crafa, P, Corrente, V, Tursi, A, Brandimarte, G, Scarpignato, C, Dal Bò, N, Cannizzaro, R, Di Mario, F

Get full text

Comparison of HER2 status in primary and paired metastatic sites of gastric carcinoma by Bozzetti, C, Negri, F V, Lagrasta, C A, Crafa, P, Bassano, C, Tamagnini, I, Gardini, G, Nizzoli, R, Leonardi, F, Gasparro, D, Camisa, R, Cavalli, S, Silini, E M, Ardizzoni, A

Get full text

HER-2/neu amplification detected by fluorescence in situ hybridization in fine needle aspirates from primary breast cancer by Bozzetti, C., Nizzoli, R., Guazzi, A., Flora, M., Bassano, C., Crafa, P., Naldi, N., Cascinu, S.

“…Background: The HER-2/neu gene is amplified in 20–30% of human breast cancers and has been shown to have prognostic and predictive value for treatment with…”
Get full text

Which breast carcinomas need HER-2/neu gene study after immunohistochemical analysis? Results of combined use of antibodies against different c-erbB2 protein domains by Sapino, A, Coccorullo, Z, Cassoni, P, Ghisolfi, G, Gugliotta, P, Bongiovanni, M, Arisio, R, Crafa, P, Bussolati, G

“…Aims:  Evaluation of HER2 gene amplification in breast cancers is a compelling, routine procedure. The aim of this work was to evaluate which breast carcinomas…”
Get full text

P.1.325: USEFULNESS OF SERUM PEPSINOGENS TO IDENTIFY CHRONIC ATROP H IC GASTRITIS by Iori, A, Gatta, L, Valenza, D, Crafa, P, Caruana, P, Perazzo, P, Franzè, J, Vaira, B, Cavestro, G.M, Franzè, A, Rugge, M, Scarpignato, C, Di Mario, F

Get full text

Prospective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas by Bashir, S., Gibril, F., Ojeaburu, J. V., Asgharian, B., Entsuah, L. K., Ferraro, G., Crafa, P., Bordi, C., Jensen, R. T.

“…Background: Chronic hypergastrinaemia causes gastric enterochromaffin cell proliferation and carcinoid tumours. The only reliable means to diagnose…”
Get full text

Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery by Carbognani, P, Tincani, G, Crafa, P, Sansebastiano, G, Pazzini, L, Zoni, R, Bobbio, A, Rusca, M

“…The biological markers in non-small cell lung cancer (NSCLC) have been widely studied and encouraging results have shown that products of some oncogenes and…”
Get full text

88P Identification of prognostic radio-immune-genetic profiles in patients affected by glioblastoma by Mazzaschi, G., Olivari, A., Dall'Asta, S., Lagrasta, C.A., Frati, C., Madeddu, D., Pavarani, A., Tiseo, M., Michiara, M., Quaini, F., Crafa, P.

Get full text

P.01.16 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: AN 11 YEARS POPULATION STUDY by Cavatorta, O., Franceschi, M., Crafa, P., Miraglia, C., Baldassarre, G., Franzoni, L., Di Mario, F.

Get full text

T04.01.12 USEFULNESS OF FECAL CALPROTECTIN IN PRIMARY CARE SETTING: AN EXPERIENCE IN NORTH – EAST ITALY POPULATION by Moccia, F., Ferronato, A., Barchi, A., Miraglia, C., Russo, M., Franceschi, M., Rodriguez-Castro, K., Baldassarre, G., Franzoni, L., Crafa, P., Tursi, A., Brandimarte, G., Di Mario, F.

Get full text

T01.01.24 RISK FACTORS OF EARLY AND ADVANCED GASTRIC CANCER: A 8 YEARS POPULATION STUDY IN NORTHERN ITALY by Cavatorta, O., Miraglia, C., Franceschi, M., Crafa, P., Baldassarre, G., Franzoni, L., Rugge, M., Barchi, A., Russo, M., Tursi, A., Brandimarte, G., Cannizzaro, R., Di Mario, F.

Get full text